The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit-sharing

By J. White. 2001

190 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/e3f2d9a2bfb653795e44a3d481a27b17ca016208

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pollution

Citations in the corpus

Cost-Benefit Analysis and the Environment: Recent Developments (2006, background): “No consistent tabulation of contract prices appears to be available (for limited information see ten Kate and Laird, 1999), but various efforts have been made to estimate what a bioprospector would be willing to pay for forest genetic material, especially Simpson et al. (1996), Craft and Simpson…”
Developing incentives and economic mechanisms for in situ biodiversity conservation in agricultural landscapes (2007, background): “…clauses imposed by the UN Convention of Biological Diversity with regard to bioprospection endeavours regarding plant genetic resources (ten Kate and Laird, 1999), This necessitates to effectively assert the property of bioresources and genetic resources in particular to the source country…”
Economic valuation of biodiversity: A comparative study (2008, background): “Since then, INBio has signed contracts on the supply of genetic resources with Bristol-Myers Squibb, other companies and non-profit organizations (ten Kate and Laird, 1999; INBio, 2001).”
DIVERSIFICATION OF TREE CROPS: DOMESTICATION OF COMPANION CROPS FOR POVERTY REDUCTION AND ENVIRONMENTAL SERVICES (2001, background): “Consequently there are important issues (reviewed by ten Kate and Laird, 1999) regarding access to these resources and the means of ensuring the sharing of bene®ts. Discussion of the role of tree domestication, however, cannot be divorced from that of product commercialization since, without…”
Agroforestry Tree Products (AFTPs): Targeting Poverty Reduction and Enhanced Livelihoods (2005, background): “Important areas for more study are the complex issues surrounding commercialisation of genetic resources and benefit sharing (ten Kate & Laird, 1999) and traditional knowledge (Laird, 2002).”
Capturing the complexity of biodiversity: A critical review of economic valuation studies of biological diversity (2015, background): “For a thorough study of bioprospecting contracts, see ten Kate and Laird (2000).”
The release of genetically modified crops into the environment. Part II. Overview of ecological risk assessment. (2003, background): “Biodiversity is the source of many of the world's products, including foods, fibres, pharmaceuticals , and chemicals (ten Kate and Laird, 1999).”